Obesity and GLP-1 RAs

The CardioNerds Cardiovascular Prevention Series, dives into Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease. This series also highlights the impact of obesity on cardiovascular disease risk, differential risk in specific populations, and effective strategies for counseling patients. This series is supported by unrestricted educational sponsorship from Novo Nordisk. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.

Cardiovascular Genomics

The CardioNerds Cardiovascular Genomics series is a multi-institutional collaboration made possible by contributions of stellar fellow leads and expert faculty from several programs. The field of Cardiovascular Genomics has advanced tremendously over the past two decades, having a significant clinical impact and changing the perception of the role and scope of genetic testing in several cardiovascular domains.  This series is supported by unrestricted educational sponsorship from Illumina, Inc. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.


Episode 244. Cardiovascular Genomics: Intro to Cardiovascular Genetics in Electrophysiology with Dr. James Daubert

Episode 246. Cardiovascular Genomics: Genetic Counseling & Family Screening in Arrhythmogenic Cardiomyopathies with Dr. Allison Hays and Dr. Cindy James


Episode 248. Cardiovascular Genomics: Frontiers in Clinical Genetics in Cardiovascular Prevention with Dr. Pradeep Natarajan

Lipid Series

The CardioNerds Lipid Series is a comprehensive series led by series co-chairs Dr. Rick Ferraro, cardiology fellow at The Johns Hopkins Hospital and Dr. Tommy Das, cardiology fellow at The Cleveland Clinic and produced in collaboration with the American Society For Preventive Cardiology (ASPC). This series has been possible by unrestricted support from:


131. Lipids: LDL Physiology & Function with Dr. Peter Toth

139. Lipids: LDL, Cardiovascular Events, & Disparities in Care with Dr. Keith Ferdinand


143. Lipids: (Non)-Fasting LDL & Furious Lipid Lowering with Dr. Alison Bailey


156. Lipids: Triglycerides – Pathophysiology to Clinical Outcomes with Dr. Matthew Budoff


161. Triglycerides - Deep Dive into EPA and DHA with Dr. Erin Michos


179. Lipids: Polyunsaturated Fatty Acids, Omega-3 Fatty Acids, Eicosapentaenoic acid – Mechanisms of Action with Dr. Ty Gluckman


194. Lipids: Omega-3 Fatty Acids & The Battle Of The Oils with Dr. Pam Taub


207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth


214. Lipids: Review of Icosapent Ethyl with Dr. Michael Shapiro